When Azoles Cannot Be Used: The Clinical Effectiveness of Intermittent Liposomal Amphotericin Prophylaxis in Hematology Patients

BACKGROUND: Patients unable to take azoles are a neglected group lacking a standardized approach to antifungal prophylaxis. We evaluated the effectiveness and safety of intermittent liposomal amphotericin B (L-AMB) prophylaxis in a heterogenous group of hematology patients. METHODS: A retrospective...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Open Forum Infect Dis
Auteurs principaux: Batchelor, R, Thomas, C, Gardiner, B J, Lee, S J, Fleming, S, Wei, A, Coutsouvelis, J, Ananda-Rajah, M
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2021
Sujets:
Major Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8318248/
https://ncbi.nlm.nih.gov/pubmed/34337090
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofab113
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires